Role of brain-derived neurotrophic factor receptor on the anxiety levels in rats following the acute administration of morphine

References

• 1.
  Bartoletti M, Gaiardi M, Gubellini C, Bacchi A, Babbini M. Morphine attenuation of a conditioned emotional response in post-dependent rats. Eur J Pharmacol 1990; 185: 163-167.
• 2.
  Motta V, Brando ML. Aversive and antiaversive effects of morphine in the dorsal periaqueductal gray of rats submitted to the elevated plus-maze test. Pharmacol Biochem Behav 1993; 44: 119-125.
• 3.
  Zarrindast MR, Rostami P, Zarei M, Roohbakhsh A. Intracerebroventricular effects of histaminergic agents on morphineinduced anxiolysis in the elevated plusmaze in rats. Basic Clin Pharmacol Toxicol 2005; 97: 276-281.
• 4.
  Privette T, Terrian D. Kappa opioid agonists produce anxiolytic-like behavior on the elevated plus-maze. Psychopharmacology 1995; 118: 444-450.
• 5.
  Zarrindast M-R, Babapoor-Farrokhran S, Babapoor-Farrokhran S, Rezayof A. Involvement of opioidergic system of the ventral hippocampus, the nucleus accumbens or the central amygdala in anxiety-related behavior. Life Sci 2008; 82: 1175-1181.
• 6.
  Miladi-Gorji H, Rashidy-Pour A, Fathollahi Y. Anxiety profile in morphine-dependent and withdrawn rats: effect of voluntary exercise. Physiol Behav 2012; 105: 195-202.
• 7.
  Koo JW, Mazei-Robison MS, Chaudhury D, Juarez B, LaPlant Q, Ferguson D, et al. BDNF is a negative modulator of morphine action. Science 2012; 338: 124-128.
• 8.
  Sarhan M, Pawlowski SA, Barthas F, Yalcin I, Kaufling J, Dardente H, et al. BDNF parabrachio-amygdaloid pathway in morphine-induced analgesia. Int J Neuropsychopharmacol 2013; 16: 1649-1660.
• 9.
  Quesseveur G, David D, Gaillard M, Pla P, Wu M, Nguyen H, et al. BDNF overexpression in mouse hippocampal astrocytes promotes local neurogenesis and elicits anxiolytic-like activities. Translat Psychiatry 2013; 3: e253.
• 10.
  Bergami M, Rimondini R, Santi S, Blum R, Gtz M, Canossa M. Deletion of TrkB in adult progenitors alters newborn neuron integration into hippocampal circuits and increases anxiety-like behavior. Proc Natl Acad Sci U S A. 2008; 105: 15570-15575.
• 11.
  Cazorla M, Jouvenceau A, Rose C, Guilloux J-P, Pilon C, Dranovsky A, Prmont J. Cyclotraxin-B, the first highly potent and selective TrkB inhibitor, has anxiolytic properties in mice. PLoS One 2010; 5: e9777.
• 12.
  Cazorla M, Prmont J, Mann A, Girard N, Kellendonk C, Rognan D. Identification of a lowmolecular weight TrkB antagonist with anxiolytic and antidepressant activity in mice. J Clin Invest 2011; 121: 1846-1857.
• 13.
  Kase H, Iwahashi K, Nakanishi S, Matsuda Y, Yamada K, Takahashi M, et al. K-252 compounds, novel and potent inhibitors of protein kinase C and cyclic nucleotide-dependent protein kinases. Biochem Biophys Res Commun 1987; 142: 436-440.
• 14.
  Boulle F, Kenis G, Cazorla M, Hamon M, Steinbusch HW, Lanfumey L, van den Hove DL. TrkB inhibition as a therapeutic target for CNS-related disorders. Prog Neurobiol 2012; 98: 197-206.
• 15.
  Shirayama Y, Chen AC-H, Nakagawa S, Russell DS, Duman RS. Brain-derived neurotrophic factor produces antidepressant effects in behavioral models of depression. J Neurosci 2002; 22: 3251-3261.
• 16.
  Siuciak JA, Lewis DR, Wiegand SJ, Lindsay RM. Antidepressant-like effect of brain-derived neurotrophic factor (BDNF). Pharmacol Biochem Behav 1997; 56: 131-137.
• 17.
  Eisch AJ, Bolanos CA, de Wit J, Simonak RD, Pudiak CM, Barrot M, et al. Brain-derived neurotrophic factor in the ventral midbrainnucleus accumbens pathway: a role in depression. Biol psychiatry 2003; 54: 994-1005.
• 18.
  Lu H, Cheng P-l, Lim BK, Khoshnevisrad N, Poo M-m. Elevated BDNF after cocaine withdrawal facilitates LTP in medial prefrontal cortex by suppressing GABA inhibition. Neuron 2010; 67: 821-833.
• 19.
  Berton O, McClung CA, DiLeone RJ, Krishnan V, Renthal W, Russo SJ, et al. Essential role of BDNF in the mesolimbic dopamine pathway in social defeat stress. Science 2006; 311: 864-868.
• 20.
  Torregrossa MM, Isgor C, Folk JE, Rice KC, Watson SJ, Woods JH. The delta-opioid receptor agonist (+) BW373U86 regulates BDNF mRNA expression in rats. Neuropsychopharmacology 2004; 29: 649-659.